In pediatric patients, age has more impact on dosing of vitamin K antagonists than VKORC1 or CYP2C9 genotypes (Q42910003)
Jump to navigation
Jump to search
scientific article published on September 10, 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | In pediatric patients, age has more impact on dosing of vitamin K antagonists than VKORC1 or CYP2C9 genotypes |
scientific article published on September 10, 2010 |
Statements
1 reference
In pediatric patients, age has more impact on dosing of vitamin K antagonists than VKORC1 or CYP2C9 genotypes (English)
1 reference
Kevin Dietrich
1 reference
Daria Schaffranek
1 reference
Noha Sharaf Eldin
1 reference
Yutaka Yasui
1 reference
Christof Geisen
1 reference
10 September 2010
1 reference
1 reference
116
1 reference
26
1 reference
6101-6105
1 reference
Identifiers
1 reference
1 reference